key: cord-0716881-dexptksw
authors: Guler, Nil; Siddiqui, Fakiha; Fareed, Jawed
title: Is the Reason of Increased D-Dimer Levels in COVID-19 Because of ACE-2-Induced Apoptosis in Endothelium?
date: 2020-07-13
journal: Clin Appl Thromb Hemost
DOI: 10.1177/1076029620935526
sha: 2a91c9050ae379e3d0083d22782af74b712d8a2c
doc_id: 716881
cord_uid: dexptksw

nan

and after entering the host cell, they use its organelles to produce structures of virus. To keep alive the host cell, it is important for the virus replication phase after finishing this process, to kill a host cell. This gives an advantage to the virus which can leave the host cell and spread to microenvironments. It is probable that during infection, not only the virus interferes with the apoptotic pathway but also the immune system starts to interact with the apoptotic pathways. Killing infected cells during the replication phase is important. [11] [12] [13] However, it can't always be explained simply because different viruses interfere with apoptotic pathways in different ways. It is our opinion that increased D-dimer may be the result of apoptotic endothelial cell induced coagulopathy. If apoptotic endothelial injury has a substantial role in pathogenesis, then we have to be concerned about the fate of large endothelial surface in the alveolar vascular bed of lungs. Uncontrolled apoptosis of alveolar endothelial cells can destroy oxygenation in different ways such as micro vascular apoptosis induced thrombi in the alveolar vascular bed and vascular fluid leaks to the lung tissue.

Swine acute diarrhea syndrome coronavirus (SADS-CoV) is a coronavirus that causes severe acute diarrhea. Zhang et al investigated the effects of pan-caspase inhibitors on SADS-CoV infected cells to see the role of apoptosis. They observed decreased SADS-CoV-induced apoptosis and reduced virus replication in SADS-CoV infected cells after the pan-caspase inhibitor. 14 Li et al studied infectious bronchitis virus (IBV) which is another coronavirus that showed that IBV induces apoptosis at late stages of infection. 15 Some studies investigated the virus induced apoptosis of endothelial cells. Sumikoshi et al demonstrated that human influenza virus can infect and induce apoptosis in the human umbilical vein endothelial cells (HUVECs). 16 It is an important finding for apoptosis in human vascular endothelial cells, which may lead to other studies for COVID-19. Another interesting study performed by Anfasa et al showed that Zika virus (ZIKV) infected HUVEC demonstrated increased apoptosis, induction in tissue factor concentration and shortened thrombin generation tests. 17 Increased levels of D-dimer and thrombosis were also clinically demonstrated in patients with ZIKV and Chikungunya. 18 These all show us that viruses can infect the endothelium and trigger the secondary hemostasis.

Armstrong et al studies infected human lung microvascular endothelium with human influenza virus. These lung cells underwent apoptosis and caused in an increase in vascular permeability. Inhibition of caspases decreased the influenzainduced endothelial leak. 19 They reported that these apoptotic findings may help to understand the pathogenesis of acute lung injury in viral pneumonias.

Another inspiring study showed that angiotensin-IIinduced apoptosis in primary pulmonary endothelial cells uses AT2 receptor. This study found the results on the activation of intrinsic pathway of apoptotic pathway due to an increased release of cytochrome c from mitochondria and activation of caspase 9. Ongoing apoptosis was blocked by an inhibitor of apoptotic protein Bax. 20 This finding brings us to whether or not to use angiotensin or AT2 receptor blockers which may help to prevent or recover from COVID-19 because SARS-CoV-2 uses ACE2 for entering to the targeted cells. 21 There is a probability that after entering the cell, SARS-CoV-2 may start the apoptotic processes in the lung microvascular bed endothelium or coronary endothelium or tissue cells which carry ACE2 receptors. We feel that the microvascular pathology can explain this virus's different clinical pictures due to tissue damage caused from vascular damage. There is also a risk for other tissue cells that carry ACE2 receptor for apoptotic damages and organ failures. There are supportive histological clues in humans on the results of ongoing apoptosis in endothelial cells. Varga et al showed apoptotic changes in endothelial cells, histologically in COVID-19. 22 We believe that the relationship between COVID-19 and apoptotic pathways contributes to the observed focal pathogenesis in the lungs and is involved in the progression of severity of the observed acute respiratory distress syndrome. Drugs with anti-apoptotic properties may therefore be helpful in the management of these patients and merit further investigations.

The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

The author(s) received no financial support for the research, authorship, and/or publication of this article.

Nil Guler https://orcid.org/0000-0003-0604-6475 Fakiha Siddiqui https://orcid.org/0000-0002-2219-7049 Jawed Fareed https://orcid.org/0000-0003-3465-2499

World Health organization. Naming the coronavirus disease (COVID-19) and the virus that causes it

Clinical characteristics of 138 hospitalizedpatients With 2019 novel coronavirus-infected pneumonia in Wuhan

Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study

Prominent changes in blood coagulation of patients with SARS-CoV-2 infection

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 Pneumonia in Wuhan, China

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID-19

Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia

Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy

Viruses and apoptosis

Dying to replicate: the orchestration of the viral life cycle, cell death pathways, and immunity

To kill or be killed: how viruses interact with the cell death machinery

Swine acute diarrhea syndrome coronavirus-induced apoptosis is caspase-and cyclophilin D-dependent

Cell cycle arrest and apoptosis induced by the coronavirus infectious bronchitis virus in the absence of p53

Human influenza virus infection and apoptosis induction in human vascular endothelial cells

Zika virus infection induces elevation of tissue factor production and apoptosis on human umbilical vein endothelial cells

Zika and chikungunya virus and risk for venous thromboembolism

Influenza infects lung microvascular endothelium leading to microvascular leak: role of apoptosis and claudin-5

Angiotensin-II-induced apoptosis requires regulation of nucleolin and Bcl-xL by SHP-2 in primary lung endothelial cells

Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus

Endothelial cell infection and endotheliitis in COVID-19